Vedere Bio
Dr. Karen Guerin is the Senior Director of Discovery Research at Vedere Bio II. Prior to joining Vedere, she was an associate director at Addgene, where she focused on AAV production and quality control. She also served as a project team leader and research investigator in gene therapy at the Novartis Institutes for BioMedical Research and was a Research Fellow at Children’s Hospital Boston. Karen holds a B.Sc in neurosciences from the University of Toulouse, an M.Sc in neurosciences and neuropharmacology from the University of Bordeaux, and a Ph.D. in vision science and molecular biology from the University of California, Berkeley.
This person is not in any offices
Vedere Bio
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.